Skip to main content
NCBI home page
Gut logoLink to Gut
. 1987 Aug;28(8):1043–1048. doi: 10.1136/gut.28.8.1043

Chronic portal systemic encephalopathy: update 1987.

S Sherlock 1
PMCID: PMC1433147  PMID: 3311906

Full text

PDF
1043

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bircher J., Müller J., Guggenheim P., Haemmerli U. P. Treatment of chronic portal-systemic encephalopathy with lactulose. Lancet. 1966 Apr 23;1(7443):890–892. doi: 10.1016/s0140-6736(66)91573-x. [DOI] [PubMed] [Google Scholar]
  2. Cerra F. B., Cheung N. K., Fischer J. E., Kaplowitz N., Schiff E. R., Dienstag J. L., Bower R. H., Mabry C. D., Leevy C. M., Kiernan T. Disease-specific amino acid infusion (F080) in hepatic encephalopathy: a prospective, randomized, double-blind, controlled trial. JPEN J Parenter Enteral Nutr. 1985 May-Jun;9(3):288–295. doi: 10.1177/0148607185009003288. [DOI] [PubMed] [Google Scholar]
  3. Chandler J. G., Fechner R. E. Hepatopedal flow restoration in patients intolerant of total portal diversion. Ann Surg. 1983 May;197(5):574–583. doi: 10.1097/00000658-198305000-00012. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Egberts E. H., Schomerus H., Hamster W., Jürgens P. Branched chain amino acids in the treatment of latent portosystemic encephalopathy. A double-blind placebo-controlled crossover study. Gastroenterology. 1985 Apr;88(4):887–895. doi: 10.1016/s0016-5085(85)80004-4. [DOI] [PubMed] [Google Scholar]
  5. Eriksson L. S., Persson A., Wahren J. Branched-chain amino acids in the treatment of chronic hepatic encephalopathy. Gut. 1982 Oct;23(10):801–806. doi: 10.1136/gut.23.10.801. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Fraser C. L., Arieff A. I. Hepatic encephalopathy. N Engl J Med. 1985 Oct 3;313(14):865–873. doi: 10.1056/NEJM198510033131406. [DOI] [PubMed] [Google Scholar]
  7. Greenberger N. J., Carley J., Schenker S., Bettinger I., Stamnes C., Beyer P. Effect of vegetable and animal protein diets in chronic hepatic encephalopathy. Am J Dig Dis. 1977 Oct;22(10):845–855. doi: 10.1007/BF01076158. [DOI] [PubMed] [Google Scholar]
  8. Hanna S. S., Smith R. S., 3rd, Henderson J. M., Millikan W. J., Jr, Warren W. D. Reversal of hepatic encephalopathy after occlusion of total portasystemic shunts. Am J Surg. 1981 Aug;142(2):285–289. doi: 10.1016/0002-9610(81)90294-4. [DOI] [PubMed] [Google Scholar]
  9. Hansen B. A., Vilstrup H. Increased intestinal hydrolysis of urea in patients with alcoholic cirrhosis. Scand J Gastroenterol. 1985 Apr;20(3):346–350. doi: 10.3109/00365528509091662. [DOI] [PubMed] [Google Scholar]
  10. Horst D., Grace N. D., Conn H. O., Schiff E., Schenker S., Viteri A., Law D., Atterbury C. E. Comparison of dietary protein with an oral, branched chain-enriched amino acid supplement in chronic portal-systemic encephalopathy: a randomized controlled trial. Hepatology. 1984 Mar-Apr;4(2):279–287. doi: 10.1002/hep.1840040218. [DOI] [PubMed] [Google Scholar]
  11. Hoyumpa A. M. The unfolding GABA story. Hepatology. 1986 Sep-Oct;6(5):1042–1044. doi: 10.1002/hep.1840060538. [DOI] [PubMed] [Google Scholar]
  12. James J. H., Ziparo V., Jeppsson B., Fischer J. E. Hyperammonaemia, plasma aminoacid imbalance, and blood-brain aminoacid transport: a unified theory of portal-systemic encephalopathy. Lancet. 1979 Oct 13;2(8146):772–775. doi: 10.1016/s0140-6736(79)92119-6. [DOI] [PubMed] [Google Scholar]
  13. Jones E. A., Schafer D. F., Ferenci P., Pappas S. C. The neurobiology of hepatic encephalopathy. Hepatology. 1984 Nov-Dec;4(6):1235–1242. doi: 10.1002/hep.1840040624. [DOI] [PubMed] [Google Scholar]
  14. Lanthier P. L., Morgan M. Y. Lactitol in the treatment of chronic hepatic encephalopathy: an open comparison with lactulose. Gut. 1985 Apr;26(4):415–420. doi: 10.1136/gut.26.4.415. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. McGhee A., Henderson J. M., Millikan W. J., Jr, Bleier J. C., Vogel R., Kassouny M., Rudman D. Comparison of the effects of Hepatic-Aid and a Casein modular diet on encephalopathy, plasma amino acids, and nitrogen balance in cirrhotic patients. Ann Surg. 1983 Mar;197(3):288–293. doi: 10.1097/00000658-198303000-00008. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Morgan M. H., Read A. E., Speller D. C. Treatment of hepatic encephalopathy with metronidazole. Gut. 1982 Jan;23(1):1–7. doi: 10.1136/gut.23.1.1. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Morgan M. Y., Hawley K. E., Stambuk D. Lactitol versus lactulose in the treatment of chronic hepatic encephalopathy. A double-blind, randomised, cross-over study. J Hepatol. 1987 Apr;4(2):236–244. doi: 10.1016/s0168-8278(87)80086-7. [DOI] [PubMed] [Google Scholar]
  18. Morgan M. Y., Jakobovits A. W., James I. M., Sherlock S. Successful use of bromocriptine in the treatment of chronic hepatic encephalopathy. Gastroenterology. 1980 Apr;78(4):663–670. [PubMed] [Google Scholar]
  19. Morgan M. Y., Milsom J. P., Sherlock S. Plasma ratio of valine, leucine and isoleucine to phenylalanine and tyrosine in liver disease. Gut. 1978 Nov;19(11):1068–1073. doi: 10.1136/gut.19.11.1068. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Nelson D. C., McGrew W. R., Jr, Hoyumpa A. M., Jr Hypernatremia and lactulose therapy. JAMA. 1983 Mar 11;249(10):1295–1298. [PubMed] [Google Scholar]
  21. Parkes J. D., Murray-Lyon I. M., Williams R. Neuropsychiatric and electro-encephalographic changes after transplantation of the liver. Q J Med. 1970 Oct;39(156):515–527. [PubMed] [Google Scholar]
  22. Potts J. R., 3rd, Henderson J. M., Millikan W. J., Jr, Sones P., Warren W. D. Restoration of portal venous perfusion and reversal of encephalopathy by balloon occlusion of portal systemic shunt. Gastroenterology. 1984 Jul;87(1):208–212. [PubMed] [Google Scholar]
  23. Schomerus H., Hamster W., Blunck H., Reinhard U., Mayer K., Dölle W. Latent portasystemic encephalopathy. I. Nature of cerebral functional defects and their effect on fitness to drive. Dig Dis Sci. 1981 Jul;26(7):622–630. doi: 10.1007/BF01367675. [DOI] [PubMed] [Google Scholar]
  24. Tarter R. E., Hegedus A. M., Van Thiel D. H., Schade R. R., Gavaler J. S., Starzl T. E. Nonalcoholic cirrhosis associated with neuropsychological dysfunction in the absence of overt evidence of hepatic encephalopathy. Gastroenterology. 1984 Jun;86(6):1421–1427. [PMC free article] [PubMed] [Google Scholar]
  25. Uribe M., Márquez M. A., García-Ramos G., Escobedo V., Murillo H., Guevara L., Lisker R. Treatment of chronic portal-systemic encephalopathy with lactose in lactase-deficient patients. Dig Dis Sci. 1980 Dec;25(12):924–928. doi: 10.1007/BF01308043. [DOI] [PubMed] [Google Scholar]
  26. Wahren J., Denis J., Desurmont P., Eriksson L. S., Escoffier J. M., Gauthier A. P., Hagenfeldt L., Michel H., Opolon P., Paris J. C. Is intravenous administration of branched chain amino acids effective in the treatment of hepatic encephalopathy? A multicenter study. Hepatology. 1983 Jul-Aug;3(4):475–480. doi: 10.1002/hep.1840030402. [DOI] [PubMed] [Google Scholar]
  27. Weber F. L., Jr, Fresard K. M., Lally B. R. Effects of lactulose and neomycin on urea metabolism in cirrhotic subjects. Gastroenterology. 1982 Feb;82(2):213–217. [PubMed] [Google Scholar]
  28. Weber F. L., Jr, Minco D., Fresard K. M., Banwell J. G. Effects of vegetable diets on nitrogen metabolism in cirrhotic subjects. Gastroenterology. 1985 Sep;89(3):538–544. doi: 10.1016/0016-5085(85)90448-2. [DOI] [PubMed] [Google Scholar]

Articles from Gut are provided here courtesy of BMJ Publishing Group

RESOURCES